Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation

American Journal of Cardiology

Volumn 115, Issue 8, 2015, Pages 1123-1129

  De Backer, Ole ^a   Arnous, Samer ^a   Sandholt, Benjamin ^a   Brooks, Matthew ^a   Biasco, Luigi ^a   Franzen, Olaf ^a   Lönn, Lars ^a   Bech, Bo ^a   Søndergaard, Lars ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTERY PROSTHESIS; ARTICLE; BLOOD VESSEL INJURY; CLAUDICATION; CONTROLLED STUDY; DEEP FEMORAL ARTERY; ECHOGRAPHY; ENDOPROSTHESIS; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS AORTIC VALVE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSTHESIS FAILURE; STENT FRACTURE; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; VASCULAR ACCESS COMPLICATION; VERY ELDERLY; ADVERSE EFFECTS; ANGIOGRAPHY; AORTIC VALVE STENOSIS; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; COMPUTER ASSISTED TOMOGRAPHY; ENDOVASCULAR SURGERY; FEMORAL ARTERY; HEART CATHETERIZATION; PROCEDURES; PROSTHESIS; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC VALVE STENOSIS; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; CARDIAC CATHETERIZATION; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; PROSTHESIS DESIGN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84930247151     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.01.547     Document Type: Article

References (16)

1. Schäfer U, Ho Y, Frerker C, Schewel D, Sanchez-Quintana D, Schofer J, Bijuklic K, Meincke F, Thielsen T, Kreidel F, Kuck KH. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach". JACC Cardiovasc Interv 2012;5:477-486.
2. Nakamura M, Chakravarty T, Jilaihawi H, Doctor N, Dohad S, Fontana G, Cheng W, Makkar RR. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure. Catheter Cardiovasc Interv 2014;84:293-300.
3. Hayashida K, Lefèvre T, Chevalier B, Hovasse T, Romano M, Garot P, Mylotte D, Uribe J, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Morice MC. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. JACC Cardiovasc Interv 2012;5:207-214.
4. Toggweiler S, Leipsic J, Binder RK, Freeman M, Barbanti M, Heijmen RH, Wood DA, Webb JG. Management of vascular access in transcatheter aortic valve replacement: part 2: vascular complications. JACC Cardiovasc Interv 2013;6:767-776.
5. Toggweiler S, Webb JG. Challenges in transcatheter aortic valve implantation. Swiss Med Wkly 2012;142:w13735.
6. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438-1454.
7. Généreux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, Davidson CJ, Eisenhauer AC, Makkar RR, Bergman GW, Babaliaros V, Bavaria JE, Velazquez OC, Williams MR, Hueter I, Xu K, Leon MB. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER trial. J Am Coll Cardiol 2012;60:1043-1052.
8. Généreux P, Kodali S, Leon MB, Smith CR, Ben-Gal Y, Kirtane AJ, Daneault B, Reiss GR, Moses JW, Williams MR. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc Interv 2011;4:861-867.
9. Khatri PJ, Webb JG, Rodés-Cabau J, Fremes SE, Ruel M, Lau K, Guo H, Wijeysundera HC, Ko DT. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med 2013;158:35-46.
10. Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv 2010;3:1110-1121.
11. Van Mieghem NM, Nuis RJ, Piazza N, Apostolos T, Ligthart J, Schultz C, de Jaegere PP, Serruys PW. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 2010;5:673-679.
12. Nuis RJ, Piazza N, Van Mieghem NM, Otten AM, Tzikas A, Schultz CJ, van der Boon R, van Geuns RJ, van Domburg RT, Koudstaal PJ, Kappetein AP, Serruys PW, de Jaegere PP. In-hospital complications after transcatheter aortic valve implantation revisited according to the Valve Academic Research Consortium definitions. Catheter Cardiovasc Interv 2011;78:457-467.
13. Mwipatayi BP, Picardo A, Masilonyane-Jones TV, Larbalestier R, Thomas S, Turner J, Vijayan V, Yong G. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation. J Vasc Surg 2013;58:1028-1036.
14. Wenaweser P, Stortecky S, Heg D, Tueller D, Nietlispach F, Falk V, Pedrazzini G, Jeger R, Reuthebuch O, Carrel T, Räber L, Amann FW, Ferrari E, Toggweiler S, Noble S, Roffi M, Gruenenfelder J, Jüni P, Windecker S, Huber C. Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry. EuroIntervention 2014;10:982-989.
15. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working group. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45:5-67.
16. Calligaro KD, Balraj P, Moudgill N, Rao A, Dougherty MJ, Eisenberg J. Results of polytetra-fluoroethylene-covered nitinol stents crossing the inguinal ligament. J Vasc Surg 2013;57:421-426.